MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,895,000 | -72.8% | 55,191 | -82.7% | 0.00% | -50.0% |
Q2 2020 | $10,640,000 | +38.5% | 319,827 | +13.2% | 0.00% | 0.0% |
Q1 2020 | $7,683,000 | -25.4% | 282,437 | -45.9% | 0.00% | 0.0% |
Q4 2019 | $10,301,000 | +33.6% | 522,111 | -12.3% | 0.00% | 0.0% |
Q3 2019 | $7,713,000 | +34.5% | 595,212 | +29.2% | 0.00% | 0.0% |
Q2 2019 | $5,733,000 | +594.1% | 460,537 | +709.7% | 0.00% | – |
Q1 2019 | $826,000 | -57.7% | 56,876 | -67.9% | 0.00% | -100.0% |
Q4 2018 | $1,954,000 | -69.9% | 176,965 | -28.4% | 0.00% | -50.0% |
Q3 2018 | $6,497,000 | +52.0% | 247,040 | +18.2% | 0.00% | +100.0% |
Q2 2018 | $4,275,000 | +41.5% | 209,070 | +25.6% | 0.00% | 0.0% |
Q1 2018 | $3,021,000 | +12.7% | 166,470 | -13.4% | 0.00% | 0.0% |
Q4 2017 | $2,681,000 | -12.2% | 192,189 | +16.4% | 0.00% | 0.0% |
Q3 2017 | $3,055,000 | +25.1% | 165,120 | +14.2% | 0.00% | 0.0% |
Q2 2017 | $2,443,000 | -66.6% | 144,567 | -73.6% | 0.00% | 0.0% |
Q1 2017 | $7,310,000 | -1.1% | 547,448 | +11.4% | 0.00% | 0.0% |
Q4 2016 | $7,394,000 | +824.2% | 491,310 | +618.3% | 0.00% | – |
Q3 2016 | $800,000 | +18.3% | 68,395 | +9.3% | 0.00% | – |
Q2 2016 | $676,000 | +30.5% | 62,566 | +11.6% | 0.00% | – |
Q1 2016 | $518,000 | -50.0% | 56,042 | -19.7% | 0.00% | – |
Q4 2015 | $1,035,000 | +101.4% | 69,759 | +123.0% | 0.00% | – |
Q3 2015 | $514,000 | -14.5% | 31,289 | +18.7% | 0.00% | – |
Q2 2015 | $601,000 | +49.1% | 26,361 | -0.8% | 0.00% | – |
Q1 2015 | $403,000 | -91.6% | 26,565 | -93.3% | 0.00% | -100.0% |
Q4 2014 | $4,789,000 | -6.9% | 397,707 | -12.4% | 0.00% | 0.0% |
Q3 2014 | $5,146,000 | +992.6% | 453,830 | +1066.4% | 0.00% | – |
Q2 2014 | $471,000 | -79.6% | 38,908 | -80.4% | 0.00% | -100.0% |
Q1 2014 | $2,313,000 | -22.4% | 198,556 | +17.7% | 0.00% | 0.0% |
Q4 2013 | $2,982,000 | +43.2% | 168,723 | +16.6% | 0.00% | 0.0% |
Q3 2013 | $2,082,000 | +376.4% | 144,680 | +399.5% | 0.00% | – |
Q2 2013 | $437,000 | – | 28,967 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |